Gadoterate Meglumine

FDA Approved: * April 11, 2022
Pharm Company: * JIANGSU HENGRUI MED
Category: Diagnostic Aid

Gadoteric acid, sold under the brand name Dotarem among others, is a macrocycle-structured gadolinium-based MRI contrast agent (GBCA). It consists of the organic acid DOTA as a chelating agent, and gadolinium (Gd3+), and is used in form of the meglumine salt (gadoterate meglumine).[3][4] The paramagnetic property of gadoteric acid reduces the T1 relaxation time (and to some extent the T2 and T2* relaxation times) in MRI, which is the source of its clinical uti... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Gadoterate Meglumine 376.9 mg/ml Intravenous Injection
NDC: 65219-080
Labeler:
Fresenius Kabi USA, LLC
Gadoterate Meglumine 376.9 mg/ml Intravenous Injection
NDC: 65219-082
Labeler:
Fresenius Kabi USA, LLC
Gadoterate Meglumine 376.9 mg/ml Intravenous Injection
NDC: 65219-084
Labeler:
Fresenius Kabi USA, LLC
Gadoterate Meglumine 376.9 mg/ml Intravenous Injection
NDC: 65219-086
Labeler:
Fresenius Kabi USA, LLC
Gadoterate Meglumine 376.9 mg/ml Intravenous Injection
NDC: 65219-088
Labeler:
Fresenius Kabi USA, LLC

Related Brands

Drugs with the same active ingredients